QUOTE AND NEWS
Forbes  Nov 28  Comment 
Eli Lilly's growth outlook contiues to improve through cutting costs and launching of several new drugs
Wall Street Journal  Nov 27  Comment 
Pfizer and Eli Lilly have raised the price of their erectile-dysfunction drugs Viagra and Cialis almost in lockstep over the past few years, a common practice in the pharmaceutical industry.
MarketWatch  Nov 25  Comment 
Biogen is using the same scientific approach to treating the disease as Eli Lilly.
Benzinga  Nov 25  Comment 
Marc Goodman of UBS lowered his EPS estimates for Eli Lilly and Co (NYSE: LLY) after the company announced that its Alzheimer's drug solanezumab failed to slow the cognitive decline in patients. Goodman, who previously had modeled about $1.1...
Benzinga  Nov 25  Comment 
  Jefferies downgraded Headwaters Inc (NYSE: HW) from Buy to Hold. Headwaters shares rose 0.19 percent to close at $23.57 on Wednesday. Analysts at BMO Capital downgraded Eli Lilly and Co (NYSE: LLY) from Outperform to Market Perform....
Benzinga  Nov 25  Comment 
Eli Lilly and Co (NYSE: LLY) fell steeply Wednesday after it announced that its Alzheimer's disease treatment candidate solanezumab didn't meet the primary endpoint in a late-stage clinical trial dubbed EXPEDITION3. In a sympathy move, Biogen...
Wall Street Journal  Nov 25  Comment 
Eli Lilly’s Alzheimer’s drug trial failure spotlights the industry’s main problem.
newratings.com  Nov 25  Comment 
INDIANAPOLIS (dpa-AFX) - Cascadian Therapeutics Inc. (CASC) is all set to implement a 1-for-6 reverse stock split on November 29, 2016. A proposal authorizing the board of directors of the company to effect a reduction in the number of authorized...
New York Times  Nov 23  Comment 
The company said the drug, solanezumab, had not helped patients with mild symptoms of the disease, a result that may affect prospects for similar tests that are underway.




Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki